These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15866756)

  • 1. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer.
    Rossner P; Boffetta P; Ceppi M; Bonassi S; Smerhovsky Z; Landa K; Juzova D; Srám RJ
    Environ Health Perspect; 2005 May; 113(5):517-20. PubMed ID: 15866756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
    Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
    Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries.
    Bonassi S; Norppa H; Ceppi M; Strömberg U; Vermeulen R; Znaor A; Cebulska-Wasilewska A; Fabianova E; Fucic A; Gundy S; Hansteen IL; Knudsen LE; Lazutka J; Rossner P; Sram RJ; Boffetta P
    Carcinogenesis; 2008 Jun; 29(6):1178-83. PubMed ID: 18356148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe.
    Boffetta P; van der Hel O; Norppa H; Fabianova E; Fucic A; Gundy S; Lazutka J; Cebulska-Wasilewska A; Puskailerova D; Znaor A; Kelecsenyi Z; Kurtinaitis J; Rachtan J; Forni A; Vermeulen R; Bonassi S
    Am J Epidemiol; 2007 Jan; 165(1):36-43. PubMed ID: 17071846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    IARC Sci Publ; 2004; (157):207-15. PubMed ID: 15055297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.
    Bonassi S; Hagmar L; Strömberg U; Montagud AH; Tinnerberg H; Forni A; Heikkilä P; Wanders S; Wilhardt P; Hansteen IL; Knudsen LE; Norppa H
    Cancer Res; 2000 Mar; 60(6):1619-25. PubMed ID: 10749131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)].
    Lando C; Hagmar L; Bonassi S
    Med Lav; 1998; 89(2):124-31. PubMed ID: 9673102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation associated with chromosomal aberration frequency: A genome-wide association study.
    Niazi Y; Thomsen H; Smolkova B; Vodickova L; Vodenkova S; Kroupa M; Vymetalkova V; Kazimirova A; Barancokova M; Volkovova K; Staruchova M; Hoffmann P; Nöthen MM; Dušinská M; Musak L; Vodicka P; Hemminki K; Försti A
    Environ Mol Mutagen; 2019 Jan; 60(1):17-28. PubMed ID: 30368896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations.
    Smerhovsky Z; Landa K; Rössner P; Brabec M; Zudova Z; Hola N; Pokorna Z; Mareckova J; Hurychova D
    Environ Health Perspect; 2001 Jan; 109(1):41-5. PubMed ID: 11171523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage.
    Brøgger A; Hagmar L; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Genet Cytogenet; 1990 Mar; 45(1):85-92. PubMed ID: 2302690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations.
    Smerhovsky Z; Landa K; Rössner P; Juzova D; Brabec M; Zudova Z; Hola N; Zarska H; Nevsimalova E
    Mutat Res; 2002 Feb; 514(1-2):165-76. PubMed ID: 11815255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.
    Hagmar L; Brøgger A; Hansteen IL; Heim S; Högstedt B; Knudsen L; Lambert B; Linnainmaa K; Mitelman F; Nordenson I
    Cancer Res; 1994 Jun; 54(11):2919-22. PubMed ID: 8187078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area.
    Liou SH; Lung JC; Chen YH; Yang T; Hsieh LL; Chen CJ; Wu TN
    Cancer Res; 1999 Apr; 59(7):1481-4. PubMed ID: 10197617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis.
    Hagmar L; Strömberg U; Tinnerberg H; Mikoczy Z
    Int J Hyg Environ Health; 2001 Oct; 204(1):43-7. PubMed ID: 11725344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective.
    Bonassi S; Znaor A; Norppa H; Hagmar L
    Cytogenet Genome Res; 2004; 104(1-4):376-82. PubMed ID: 15162068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde.
    Musak L; Smerhovsky Z; Halasova E; Osina O; Letkova L; Vodickova L; Polakova V; Buchancova J; Hemminki K; Vodicka P
    Scand J Work Environ Health; 2013 Nov; 39(6):618-30. PubMed ID: 23525098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations and SCEs as biomarkers of cancer risk.
    Norppa H; Bonassi S; Hansteen IL; Hagmar L; Strömberg U; Rössner P; Boffetta P; Lindholm C; Gundy S; Lazutka J; Cebulska-Wasilewska A; Fabiánová E; Srám RJ; Knudsen LE; Barale R; Fucic A
    Mutat Res; 2006 Aug; 600(1-2):37-45. PubMed ID: 16814813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts.
    Hagmar L; Strömberg U; Bonassi S; Hansteen IL; Knudsen LE; Lindholm C; Norppa H
    Cancer Res; 2004 Mar; 64(6):2258-63. PubMed ID: 15026371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations after exposure to low doses of ionizing radiation.
    Milacic S
    J BUON; 2009; 14(4):641-6. PubMed ID: 20148456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.